ABBOTT LABORATORIES (ABT) Fundamental Analysis & Valuation

NYSE:ABT • US0028241000

110.25 USD
-0.3 (-0.27%)
At close: Mar 11, 2026
109.21 USD
-1.04 (-0.94%)
After Hours: 3/11/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ABT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Overall ABT gets a fundamental rating of 7 out of 10. We evaluated ABT against 184 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making ABT a very profitable company, without any liquidiy or solvency issues. ABT is not valued too expensively and it also shows a decent growth rate. ABT also has an excellent dividend rating. These ratings would make ABT suitable for dividend and quality investing!


Dividend Valuation Growth Profitability Health

8

1. ABT Profitability Analysis

1.1 Basic Checks

  • In the past year ABT was profitable.
  • ABT had a positive operating cash flow in the past year.
  • In the past 5 years ABT has always been profitable.
  • Each year in the past 5 years ABT had a positive operating cash flow.
ABT Yearly Net Income VS EBIT VS OCF VS FCFABT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.52%, ABT belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
  • ABT has a Return On Equity of 12.51%. This is amongst the best in the industry. ABT outperforms 88.04% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 9.17%, ABT belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ABT is in line with the industry average of 9.15%.
  • The last Return On Invested Capital (9.17%) for ABT is above the 3 year average (8.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROIC 9.17%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ABT Yearly ROA, ROE, ROICABT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • The Profit Margin of ABT (14.72%) is better than 90.76% of its industry peers.
  • In the last couple of years the Profit Margin of ABT has grown nicely.
  • ABT has a Operating Margin of 18.85%. This is amongst the best in the industry. ABT outperforms 90.22% of its industry peers.
  • ABT's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 56.68%, ABT is in line with its industry, outperforming 57.07% of the companies in the same industry.
  • ABT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.85%
PM (TTM) 14.72%
GM 56.68%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
ABT Yearly Profit, Operating, Gross MarginsABT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ABT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ABT is destroying value.
  • The number of shares outstanding for ABT has been increased compared to 1 year ago.
  • The number of shares outstanding for ABT has been reduced compared to 5 years ago.
  • ABT has a better debt/assets ratio than last year.
ABT Yearly Shares OutstandingABT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
ABT Yearly Total Debt VS Total AssetsABT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • ABT has an Altman-Z score of 5.09. This indicates that ABT is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 5.09, ABT is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
  • ABT has a debt to FCF ratio of 1.75. This is a very positive value and a sign of high solvency as it would only need 1.75 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.75, ABT belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
  • ABT has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.19, ABT perfoms like the industry average, outperforming 59.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Altman-Z 5.09
ROIC/WACC0.94
WACC9.74%
ABT Yearly LT Debt VS Equity VS FCFABT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 1.58 indicates that ABT should not have too much problems paying its short term obligations.
  • ABT's Current ratio of 1.58 is on the low side compared to the rest of the industry. ABT is outperformed by 72.83% of its industry peers.
  • A Quick Ratio of 1.18 indicates that ABT should not have too much problems paying its short term obligations.
  • ABT has a worse Quick ratio (1.18) than 69.57% of its industry peers.
  • ABT does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.18
ABT Yearly Current Assets VS Current LiabilitesABT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ABT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 10.28% over the past year.
  • Measured over the past 5 years, ABT shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
  • Looking at the last year, ABT shows a small growth in Revenue. The Revenue has grown by 5.67% in the last year.
  • The Revenue has been growing slightly by 5.08% on average over the past years.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%

3.2 Future

  • Based on estimates for the next years, ABT will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.38% on average per year.
  • ABT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.06% yearly.
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABT Yearly Revenue VS EstimatesABT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
ABT Yearly EPS VS EstimatesABT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. ABT Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 21.41 indicates a rather expensive valuation of ABT.
  • ABT's Price/Earnings ratio is a bit cheaper when compared to the industry. ABT is cheaper than 79.35% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ABT to the average of the S&P500 Index (26.15), we can say ABT is valued inline with the index average.
  • Based on the Price/Forward Earnings ratio of 19.19, the valuation of ABT can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, ABT is valued cheaper than 80.98% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.27. ABT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.41
Fwd PE 19.19
ABT Price Earnings VS Forward Price EarningsABT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 76.63% of the companies in the same industry are more expensive than ABT, based on the Enterprise Value to EBITDA ratio.
  • 80.98% of the companies in the same industry are more expensive than ABT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 25.91
EV/EBITDA 17.01
ABT Per share dataABT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABT does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of ABT may justify a higher PE ratio.
PEG (NY)1.86
PEG (5Y)3
EPS Next 2Y10.76%
EPS Next 3Y10.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. ABT Dividend Analysis

5.1 Amount

  • ABT has a Yearly Dividend Yield of 2.27%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.21, ABT pays a better dividend. On top of this ABT pays more dividend than 96.74% of the companies listed in the same industry.
  • ABT's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.27%

5.2 History

  • The dividend of ABT is nicely growing with an annual growth rate of 10.37%!
  • ABT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ABT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.37%
Div Incr Years34
Div Non Decr Years34
ABT Yearly Dividends per shareABT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • ABT pays out 63.09% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of ABT is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
ABT Yearly Income VS Free CF VS DividendABT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ABT Dividend Payout.ABT Dividend Payout, showing the Payout Ratio.ABT Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABT Fundamentals: All Metrics, Ratios and Statistics

ABBOTT LABORATORIES

NYSE:ABT (3/11/2026, 8:04:00 PM)

After market: 109.21 -1.04 (-0.94%)

110.25

-0.3 (-0.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-14
Inst Owners81.83%
Inst Owner Change3.57%
Ins Owners0.47%
Ins Owner Change1.1%
Market Cap191.58B
Revenue(TTM)44.33B
Net Income(TTM)6.52B
Analysts80
Price Target136.02 (23.37%)
Short Float %0.99%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield 2.27%
Yearly Dividend2.37
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years34
Div Non Decr Years34
Ex-Date04-15
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)0%
PT rev (3m)-7.35%
EPS NQ rev (1m)0.04%
EPS NQ rev (3m)-4.33%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.2%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.88%
Valuation
Industry RankSector Rank
PE 21.41
Fwd PE 19.19
P/S 4.32
P/FCF 25.91
P/OCF 20.03
P/B 3.68
P/tB 8.49
EV/EBITDA 17.01
EPS(TTM)5.15
EY4.67%
EPS(NY)5.74
Fwd EY5.21%
FCF(TTM)4.26
FCFY3.86%
OCF(TTM)5.51
OCFY4.99%
SpS25.51
BVpS30
TBVpS12.99
PEG (NY)1.86
PEG (5Y)3
Graham Number58.96
Profitability
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROCE 11.9%
ROIC 9.17%
ROICexc 10.51%
ROICexgc 20.3%
OM 18.85%
PM (TTM) 14.72%
GM 56.68%
FCFM 16.68%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Debt/EBITDA 0.86
Cap/Depr 69.67%
Cap/Sales 4.9%
Interest Coverage 15.33
Cash Conversion 83.39%
Profit Quality 113.35%
Current Ratio 1.58
Quick Ratio 1.18
Altman-Z 5.09
F-Score6
WACC9.74%
ROIC/WACC0.94
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%
EBIT growth 1Y18.75%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%

ABBOTT LABORATORIES / ABT FAQ

What is the fundamental rating for ABT stock?

ChartMill assigns a fundamental rating of 7 / 10 to ABT.


What is the valuation status of ABBOTT LABORATORIES (ABT) stock?

ChartMill assigns a valuation rating of 5 / 10 to ABBOTT LABORATORIES (ABT). This can be considered as Fairly Valued.


What is the profitability of ABT stock?

ABBOTT LABORATORIES (ABT) has a profitability rating of 8 / 10.


What are the PE and PB ratios of ABBOTT LABORATORIES (ABT) stock?

The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABT) is 21.41 and the Price/Book (PB) ratio is 3.68.


Can you provide the expected EPS growth for ABT stock?

The Earnings per Share (EPS) of ABBOTT LABORATORIES (ABT) is expected to grow by 11.53% in the next year.